| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| K7ANV6 | AE binding protein 2; | AEBP2; | NULL | 517 | chimpanzee |
| Q5GFE1 | Impact; Fragment; | Impact; | NULL | 10 | chimpanzee |
| Q0PXR5 | MHC class I antigen; Fragment; | Patr-A; | NULL | 181 | chimpanzee |
| K7BQL7 | Membrane bound O-acyltransferase domain containing 7; | MBOAT7; | NULL | 399 | chimpanzee |
| K7BAT4 | Sterol regulatory element binding transcription factor 2; | SREBF2; | NULL | 1141 | chimpanzee |
| K7C7C8 | Mps one binder kinase activator-like 2; | MOB2; | NULL | 237 | chimpanzee |
| K7C377 | Palmitoyltransferase; EC 2.3.1.225; | ZDHHC16; | NULL | 377 | chimpanzee |
| K7C737 | PMS2 postmeiotic segregation increased 2; | PMS2; | NULL | 862 | chimpanzee |
| K7CIJ0 | Matrix-remodelling associated 5; | MXRA5; | NULL | 2853 | chimpanzee |
| K7CE74 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1; | SMARCA1; | NULL | 1053 | chimpanzee |
| K7CX54 | ATPase family, AAA domain containing 2; | ATAD2; | NULL | 1391 | chimpanzee |
| O77584 | DAZL1 protein; Fragment; | DAZL1; | NULL | 97 | chimpanzee |
| K7DFC4 | CD44 molecule; Indian blood group; | CD44; | XP_001151845.1; | 429 | chimpanzee |
| K7DHZ0 | NudE nuclear distribution gene E homolog 1; | NDE1; | NULL | 346 | chimpanzee |
| H2RC74 | Uncharacterized protein; Fragment; | TMEM8B; | NULL | 650 | chimpanzee |
| K7DFQ8 | Regulator of calcineurin 2; | RCAN2; | NULL | 197 | chimpanzee |
| K7CSQ5 | Trimethylguanosine synthase 1; | TGS1; | NULL | 855 | chimpanzee |
| K7DI37 | Cytochrome b reductase 1; | CYBRD1; | NULL | 286 | chimpanzee |
| A7L408 | Cytochrome b; Fragment; | CYTB; | NULL | 231 | chimpanzee |
| K7DKP7 | Zinc finger protein 778; | ZNF778; | NULL | 756 | chimpanzee |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |